Prof. J.H.L.M. van Bokhoven (Hans)

Principal investigator - Donders Center of Medical Neurosciences
Principal investigator - Donders Institute for Brain, Cognition and Behaviour
Professor - Faculty of Medical Sciences (Radboudumc)

Prof. J.H.L.M. van Bokhoven (Hans)
Visiting address

Geert Grooteplein zuid 10
6525 GA NIJMEGEN
Internal postal code: 855

Working days Monday, Tuesday, Wednesday, Thursday, Friday

Hans van Bokhoven is head and full professor of the unit Molecular Neurogenetics.
He is an internationally renowned expert in the elucidation of genetic and epigenetic networks that are disrupted in human brain disorders such as intellectual disability, autism and neuronal migration disorders. His research is highly multidisciplinary and besides state of the art genome-wide analyses his group uses a variety of animal models (Drosophila, mouse) and neurobiological approaches to get insight into the molecular and cellular pathways of normal and disrupted learning and memory.
Starting with patients with a cognitive disorder, his group has contributed to the identification of more than 50 causative genes, that are further used for fundamental and translational research.
Since obtaining his PhD in 1993, Hans has published more than 300 peer-reviewed papers of which many in high-impact journals; his current H-index is 70. He has received multiple highly competitive research grants (more than € 10 mln in the last 2 years and has been (co)promotor of more than 30 PhD candidates. He has been involved in many international collaborations, including two large EU-funded consortia: EURO-MRX (FP5) and GENCODYS (FP7) and Erare IMPACT of which he has been/is the coordinator.

Members of the media are kindly requested to contact the press office of Radboud university medical center, tel. + 31 (024) 361 89 10.

Projects

Curriculum Vitae

Additional positions

About
Hans van Bokhoven studies the role that genes play in the nervous system. He examines the genetic and epigenetic networks that are disrupted by human brain disorders. This knowledge contributes to the development of new therapies.